Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma-Reference-Cited by-同舟云学术

Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma

Published:1998-01 Issue:1 Volume:5 Page:54-63
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Annals of Surgical Oncology

Author:

Mooney Margaret M.,Kulas Margaret,McKinley Brian,Michalek Arthur M.,Kraybill William G.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/BF02303765.pdf

Reference22 articles.

1. American Cancer Society.Cancer Facts and Figures—1974. New York: American Cancer Society, 1974.

2. American Cancer Society.Cancer Facts and Figures—1997. Atlanta: American Cancer Society, 1997.

3. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK, eds.SEER Cancer Statistics Review, 1973–1992: Tables and Graphs. NIH Pub. No. 96-2789. Bethesda, MD: National Cancer Institute, 1995. (CD-ROM Public Access File).

4. Crowley NJ, Seigler HF. Late recurrence of malignant melanoma: analysis of 168 patients.Ann Surg 1990;212:173–7.

5. Tahery DP, Moy RL. Recurrent malignant melanoma following a 35-year disease-free interval.J Dermatol Surg Oncol 1993;19:161–3.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States;Advances in Therapy;2023-05-16

2. Malignant Cutaneous Melanoma: Updates in PET Imaging;Current Radiopharmaceuticals;2020-03-13

3. Update on Current Treatment Recommendations for Primary Cutaneous Melanoma;Dermatologic Clinics;2019-10

4. Follow-Up of Disease-Free Patients;Cutaneous Melanoma;2017

5. 18F-FDG PET/CT and Melanoma: Staging, Immune Modulation and Mutation-Targeted Therapy Assessment, and Prognosis;American Journal of Roentgenology;2015-08